- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Soma Gold Corp.
Black Swan Graphene
CI Galaxy Bitcoin ETF
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
FinCanna (CSE:CALI) has been featured in an article published by CannabisFN (CFN) Media Group regarding the company’s flagship investment in Cultivation Technologies Inc (CTI) and how it’s uniquely position in generating near term revenue.
FinCanna (CSE:CALI) has been featured in an article published by CannabisFN (CFN) Media Group regarding the company’s flagship investment in Cultivation Technologies Inc (CTI) and how it’s uniquely position in generating near term revenue. The article describes FinCanna as a “royalty company that’s focused on building a portfolio of investments in scalable, best-in-class projects in the licensed medical cannabis sector.”
The article talked about the recently launched interim medical cannabis extraction facility in advance to the permanent one in Coachella, California. The article further addressed the new regulations placed in California which increases CTI’s production capacity from 20 percent to 100 percent.
“As revenues from the extraction and manufacturing business are now expected to be the largest segment of CTI’s Coachella Campus, the increase in expected royalties to FinCanna are very significant. We continue to be impressed by CTI’s exceptional management team and support their strategic approach to the market,” said Fincanna CEO Andriyako Herchak.
Lastly, the article discussed the company’s long term ambitions to fund a variety of licensed medical cannabis operations in exchange for an ongoing royalty over time and looking ahead how is the company a unique investment opportunity for investors.
To read the full article, click here.
Click here to connect with FinCanna (CSE:CALI) for an Investor Presentation
Source: www.cannabisfn.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.